C4 Therapeutics (CCCC) Return on Assets: 2020-2025
Historic Return on Assets for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to -0.42%.
- C4 Therapeutics' Return on Assets fell 15.00% to -0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.42%, marking a year-over-year decrease of 15.00%. This contributed to the annual value of -0.29% for FY2024, which is 4.00% up from last year.
- Per C4 Therapeutics' latest filing, its Return on Assets stood at -0.42% for Q3 2025, which was down 16.98% from -0.36% recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Return on Assets ranged from a high of -0.17% in Q4 2021 and a low of -0.42% during Q3 2025.
- Moreover, its 3-year median value for Return on Assets was -0.33% (2024), whereas its average is -0.33%.
- In the last 5 years, C4 Therapeutics' Return on Assets increased by 8bps in 2024 and then fell by 15bps in 2025.
- Quarterly analysis of 5 years shows C4 Therapeutics' Return on Assets stood at -0.17% in 2021, then dropped by 10bps to -0.26% in 2022, then declined by 11bps to -0.37% in 2023, then rose by 8bps to -0.29% in 2024, then declined by 15bps to -0.42% in 2025.
- Its last three reported values are -0.42% in Q3 2025, -0.36% for Q2 2025, and -0.31% during Q1 2025.